HSAs And FSAs Were Designed to Give Consumers Control and Clarity of Their Healthcare Spending — Why Isn’t This Happening?

If HSAs and FSAs were functioning as originally intended, the rising out-of-pocket costs faced by most Americans would be met with increased financial fluency and agency.  The post HSAs And FSAs Were Designed to Give Consumers Control and Clarity of Their Healthcare Spending — Why Isn’t This Happening? appeared first on MedCity News.

Read More

Life Is Geometry

By KIM BELLARD In 2025, we’ve got DNA all figured out, right?  It’s been over fifty years since Crick and Watson (and Franklin) discovered the double helix structure. We know that permutations of just four chemical bases (A, C, T, and G) allow the vast genetic complexity and diversity in the world. We’ve done the…

Read More

Is Direct to Consumer (DTC) drug pricing an effective way to make drugs more affordable?

That is the topic of a recent BioSpace article titled “How Effective Will TrumpRx and Other Direct-to-Consumer Drug Pricing Initiatives Be?” A am quoted in the article as follows: While [direct-to-consumer] DTC has been a growing trend in biopharma for nearly two years now—Lilly launched LillyDirect in January 2024—the number of drugmakers looking to sell their…

Read More

Convention Invisibility Teaches A Crucial Health Policy Lesson

By MICHAEL MILLENSON It’s close to an iron rule: Politics drives policy. In that context, the health policy issues that were largely invisible at the Republican and Democratic conventions taught a crucial political lesson. Start with access. According to KFF (formerly the Kaiser Family Foundation), more than 25 million Americans have been disenrolled from Medicaid as of…

Read More